| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2025―Okt―21 |
Comparative Safety of Empirical Antibiotic Classes in Newly Hospitalized COVID-19 Patients |
Kalynn Park, Sohyeon Park, Jung Yoon Choi, Chaeyoon Kim, Jeongha Yun, Jiyeon Bae, Ji Yun Bae, Kang-Il Jun, Jeong-Han Kim, Chung-Jong Kim, Hee Jung Choi, Sandy Jeong Rhie |
| 2 |
[GO] |
2025―Okt―13 |
Impact of the COVID-19 Pandemic on Drug-Resistant Tuberculosis in Europe: A Meta-Analysis of Epidemiological Trends |
Christina Zouganeli, Dimitra K. Toubanaki, Ourania Karaoulani, Georgia Vrioni, Evdokia Karagouni, Antonia Efstathiou |
| 3 |
[GO] |
2025―Sep―29 |
Challenges in the Treatment of HIV-Related Lymphomas Complicated by COVID-19 |
Kinga Siewiorek, Marcin Jasiński, Błażej Izdebski, Maciej Przybylski, Małgorzata Kobylecka, Joanna Mączewska, Krzysztof Jamroziak, Joanna Drozd-Sokołowska |
| 4 |
[GO] |
2025―Sep―04 |
Anti-Oxidant, Anti-Inflammatory and Antiviral Properties of Luteolin Against SARS-CoV-2: Based on Network Pharmacology |
Xin Li, Yunmei Fu, Tong Yu, Ruizhe Song, Hongguang Nie, Yan Ding |
| 5 |
[GO] |
2025―Aug―18 |
Network Pharmacology and Experiment Verification-Based Strategy for Exploring the Mechanisms of Shuqing Granule in the Treatment of COVID-19 |
Xiaoping Guo, Haoyu Zheng, Yiming An, Yuemeng Song, Tianqi Liu, Zhengjie Zhou, Chuangui Liu, Guoqiang Wang, Fang Wang |
| 6 |
[GO] |
2025―Jul―17 |
Supercomputing Multi-Ligand Modeling, Simulation, Wavelet Analysis and Surface Plasmon Resonance to Develop Novel Combination Drugs: A Case Study of Arbidol and Baicalein Against Main Protease of SARS-CoV-2 |
Hong Li, Hailong Su, Akari Komori, Shuxuan Yang, Hailang Luo, Angela Wei Hong Yang, Xiaomin Sun, Hongwei Li, Andrew Hung, Xiaoshan Zhao |
| 7 |
[GO] |
2025―Mai―29 |
Mechanistic Exploration of Yiqi Zengmian in Regulating the Microenvironment as an Immunopotentiator with the Beijing Bio-Institute of Biological Products Coronavirus Vaccine Based on Transcriptomics and Integrated Serum Pharmacochemistry |
Zeyue Yu, Yudong Wang, Jianhui Sun, Xiaotong Zheng, Liyu Hao, Yurong Deng, Jianliang Li, Zongyuan Li, Zhongchao Shan, Weidong Li, Yuling Qiao, Ruili Huo, Yibai Xiong, Hairu Huo, Hui Li, Longfei Lin, Hanhui Huang, Guimin Liu, Aoao Wang, Hongmei Li, Luqi Huang |
| 8 |
[GO] |
2025―Mai―05 |
Efficient Delivery of SARS-CoV-2 Plasmid DNA in HEK-293T Cells Using Chitosan Nanoparticles |
Citlali Cecilia Mendoza-Guevara, Alejandro Martinez-Escobar, María del Pilar Ramos-Godínez, José Esteban Muñoz-Medina, Eva Ramon-Gallegos |
| 9 |
[GO] |
2025―Mai―02 |
Disproportionality Analysis of the Five Most Widespread Neurological Effects of COVID-19 Vaccines from 2021 to 2023: Insights from EudraVigilance |
Arturo Gómez López de las Huertas, Stefan Stewart, Mikel Urroz Elizalde, Javier Guijarro-Eguinoa, Enrique Seco-Meseguer, Elena Diago-Sempere, María Jiménez González, Antonio J. Carcas-Sansuan, Alberto M. Borobia Pérez, Elena Ramírez |
| 10 |
[GO] |
2025―Apr―18 |
Physicochemical Properties and Molecular Insights of Favipiravir and Roflumilast Solid Dispersions for COVID-19 Treatment |
Abdul Rauf, Saad Salman |
| 11 |
[GO] |
2025―Mrz―03 |
Effect of Traditional Chinese Medicine on COVID-19 Treatment: A Meta-Analysis of Randomized Clinical Trials |
Marharyta Sobczak, Rafał Pawliczak |
| 12 |
[GO] |
2025―Jan―20 |
p97 Inhibitors Possessing Antiviral Activity Against SARS-CoV-2 and Low Cytotoxicity |
Rui Ding, Tiffany C. Edwards, Prithwish Goswami, Daniel J. Wilson, Christine D. Dreis, Yihong Ye, Robert J. Geraghty, Liqiang Chen |
| 13 |
[GO] |
2024―Dez―23 |
Effect of Homologous and Heterologous Booster in COVID-19 Vaccination |
Marija Vukčević, Mateja Despot, Aleksandra Nikolić-Kokić, Duško Blagojević, Milan Nikolić, Ana Banko, Tanja Jovanović, Dragana Despot |
| 14 |
[GO] |
2024―Dez―11 |
In Vitro Screening of an In-House Library of Structurally Distinct Chemotypes Towards the Identification of Novel SARS-CoV-2 Inhibitors |
Michele Tonelli, Anna Sparatore, Ivan Bassanini, Valeria Francesconi, Fabio Sparatore, Kevin K. Maina, Serena Delbue, Sarah D’Alessandro, Silvia Parapini, Nicoletta Basilico |
| 15 |
[GO] |
2024―Nov―07 |
Design, Development and Immunogenicity Study of a Multi-Epitope Vaccine Prototype Against SARS-CoV-2 |
Mariyana Atanasova, Ivan Dimitrov, Nikola Ralchev, Aleksandar Markovski, Iliyan Manoylov, Silviya Bradyanova, Nikolina Mihaylova, Andrey Tchorbanov, Irini Doytchinova |
| 16 |
[GO] |
2024―Sep―20 |
Study of Potential Blocking Peptides Targeting the SARS-CoV-2 RBD/hACE2 Interaction |
Sara M. Villada-Troncoso, Jenny Andrea Arévalo-Romero, Vanessa Hernández Rivera, Martha Pedraza-Escalona, Sonia M. Pérez-Tapia, Angela Johana Espejo-Mojica, Carlos Javier Alméciga-Díaz |
| 17 |
[GO] |
2024―Sep―10 |
Myrtus communis L. Essential Oil Exhibits Antiviral Activity against Coronaviruses |
Dar-Yin Li, Matthew G. Donadu, Taylor Shue, Georgios Dangas, Antonis Athanasiadis, Shuiyun Lan, Xin Wen, Basem Battah, Stefania Zanetti, Vittorio Mazzarello, Stefan G. Sarafianos, Marco Ferrari, Eleftherios Michailidis |
| 18 |
[GO] |
2024―Aug―22 |
Correction: Awad et al. Repurposing Potential of the Antiparasitic Agent Ivermectin for the Treatment and/or Prophylaxis of COVID-19. Pharmaceuticals 2022, 15, 1068 |
Hoda Awad, Basmala Hassan, Sara Dweek, Yasmeen Aboelata, Mutasem Rawas-Qalaji, Iman Saad Ahmed |
| 19 |
[GO] |
2024―Aug―06 |
Drug-Drug Interactions between COVID-19 and Tuberculosis Medications: A Comprehensive Review of CYP450 and Transporter-Mediated Effects |
M. Rasheduzzaman Jony, Sangzin Ahn |
| 20 |
[GO] |
2024―Aug―05 |
Lactoferrin Binds through Its N-Terminus to the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein |
Patrik Babulic, Ondrej Cehlar, Gabriela Ondrovičová, Tetiana Moskalets, Rostislav Skrabana, Vladimir Leksa |
| 21 |
[GO] |
2024―Jul―08 |
A Dynamic and Effective Peptide-Based Strategy for Promptly Addressing Emerging SARS-CoV-2 Variants of Concern |
Michela Murdocca, Isabella Romeo, Gennaro Citro, Andrea Latini, Federica Centofanti, Antonella Bugatti, Francesca Caccuri, Arnaldo Caruso, Francesco Ortuso, Stefano Alcaro, Federica Sangiuolo, Giuseppe Novelli |
| 22 |
[GO] |
2024―Jun―24 |
Identification of South African Plant-Based Bioactive Compounds as Potential Inhibitors against the SARS-CoV-2 Receptor |
Nqobile Monate Mkolo, Clarissa Marcelle Naidoo, Rose Kadye, Chikwelu Lawrence Obi, Benson Chucks Iweriebor, Oyinlola Oluwunmi Olaokun, Earl Prinsloo, Muhammad Sulaiman Zubair |
| 23 |
[GO] |
2024―Jun―17 |
Promising Strategies to Reduce the SARS-CoV-2 Amyloid Deposition in the Brain and Prevent COVID-19-Exacerbated Dementia and Alzheimer’s Disease |
Nikita Navolokin, Viktoria Adushkina, Daria Zlatogorskaya, Valeria Telnova, Arina Evsiukova, Elena Vodovozova, Anna Eroshova, Elina Dosadina, Sergey Diduk, Oxana Semyachkina-Glushkovskaya |
| 24 |
[GO] |
2024―Jun―14 |
Novel Anti-Enterovirus A71 Compounds Discovered by Repositioning Antivirals from the Open-Source MMV Pandemic Response Box |
Nattinee Lochaiyakun, Potjanee Srimanote, Onr Khantisitthiporn, Jeeraphong Thanongsaksrikul |
| 25 |
[GO] |
2024―Mai―17 |
New Thiazolidine-4-One Derivatives as SARS-CoV-2 Main Protease Inhibitors |
Antonella Messore, Paolo Malune, Elisa Patacchini, Valentina Noemi Madia, Davide Ialongo, Merve Arpacioglu, Aurora Albano, Giuseppe Ruggieri, Francesco Saccoliti, Luigi Scipione, Enzo Tramontano, Serena Canton, Angela Corona, Sante Scognamiglio, Annalaura Paulis, Mustapha Suleiman, Helmi Mohammed Al-Maqtari, Fatma Mohamed A. Abid, Sarkar M. A. Kawsar, Murugesan Sankaranarayanan, Roberto Di Santo, Francesca Esposito, Roberta Costi |
| 26 |
[GO] |
2024―Mai―14 |
Evaluation of Serial Procalcitonin Levels for the Optimization of Antibiotic Use in Non-Critically Ill COVID-19 Patients |
Abdulaziz S. Almulhim, Mohammed A. Alabdulwahed, Fatimah F. Aldoughan, Ali M. Aldayyen, Faisal Alghamdi, Rawan Alabdulqader, Norah Alnaim, Dimah Alghannam, Yasmin Aljamaan, Saleh Almutairi, Feras T. Al Mogbel, Ahmad Alamer, Haytham A. Wali |
| 27 |
[GO] |
2024―Mai―09 |
Arylamines QSAR-Based Design and Molecular Dynamics of New Phenylthiophene and Benzimidazole Derivatives with Affinity for the C111, Y268, and H73 Sites of SARS-CoV-2 PLpro Enzyme |
Gianfranco Sabadini, Marco Mellado, César Morales, Jaime Mella |
| 28 |
[GO] |
2024―Mai―01 |
Investigating the Antiviral Properties of Nyctanthes arbor-tristis Linn against the Ebola, SARS-CoV-2, Nipah, and Chikungunya Viruses: A Computational Simulation Study |
Raed Albiheyri, Varish Ahmad, Mohammad Imran Khan, Faisal A. Alzahrani, Qazi Mohammad Sajid Jamal |
| 29 |
[GO] |
2024―Apr―05 |
Potential Anti-Inflammatory and Anti-Fatigue Effects of an Oral Food Supplement in Long COVID Patients |
Annalisa Noce, Giulia Marrone, Manuela Di Lauro, Chiara Vita, Giulia Montalto, Gloria Giorgino, Carlo Chiaramonte, Cartesio D’Agostini, Sergio Bernardini, Massimo Pieri |
| 30 |
[GO] |
2024―Apr―01 |
Unveiling the Role of PAR 1: A Crucial Link with Inflammation in Diabetic Subjects with COVID-19 |
Ravinder Singh, Varinder Singh, Md. Altamash Ahmad, Chirag Pasricha, Pratima Kumari, Thakur Gurjeet Singh, Rupinder Kaur, Somdutt Mujwar, Tanveer A. Wani, Seema Zargar |
| 31 |
[GO] |
2024―Mrz―28 |
Myrtucommulones and Related Acylphloroglucinols from Myrtaceae as a Promising Source of Multitarget SARS-CoV-2 Cycle Inhibitors |
Simony Carvalho Mendonça, Brendo Araujo Gomes, Mariana Freire Campos, Thamirys Silva da Fonseca, Maria Eduarda Alves Esteves, Bruce Veiga Andriolo, Caio Felipe de Araujo Ribas Cheohen, Larissa Esteves Carvalho Constant, Stephany da Silva Costa, Pedro Telles Calil, Amanda Resende Tucci, Thamara Kelcya Fonseca de Oliveira, Alice dos Santos Rosa, Vivian Neuza dos Santos Ferreira, Julia Nilo Henrique Lima, Milene Dias Miranda, Luciana Jesus da Costa, Manuela Leal da Silva, Marcus Tullius Scotti, Diego Allonso, Gilda Guimarães Leitão, Suzana Guimarães Leitão |
| 32 |
[GO] |
2024―Mrz―28 |
Discovery of Bacterial Key Genes from 16S rRNA-Seq Profiles That Are Associated with the Complications of SARS-CoV-2 Infections and Provide Therapeutic Indications |
Md. Kaderi Kibria, Md. Ahad Ali, Muhammad Yaseen, Imran Ahmad Khan, Mashooq Ahmad Bhat, Md. Ariful Islam, Rashidul Alam Mahumudand, Md. Nurul Haque Mollah |
| 33 |
[GO] |
2024―Mrz―25 |
Correction: Palmeira et al. Preliminary Virtual Screening Studies to Identify GRP78 Inhibitors Which May Interfere with SARS-CoV-2 Infection. Pharmaceuticals 2020, 13, 132 |
Andreia Palmeira, Emília Sousa, Aylin Köseler, Ramazan Sabirli, Tarık Gören, İbrahim Türkçüer, Özgür Kurt, Madalena M. Pinto, M. Helena Vasconcelos |
| 34 |
[GO] |
2024―Mrz―12 |
Efficacy Analysis and Prognostic Impact of Sivelestat Sodium in Coronavirus Disease 2019-Related Acute Respiratory Distress Syndrome |
Xiao Che, Wei Hu, Ziying Zhang, Lexiao Wang, Zhe Xu, Fusheng Wang |
| 35 |
[GO] |
2024―Mrz―11 |
Serious Safety Signals and Prediction Features Following COVID-19 mRNA Vaccines Using the Vaccine Adverse Event Reporting System |
Jung Yoon Choi, Yongjoon Lee, Nam Gi Park, Mi Sung Kim, Sandy Jeong Rhie |
| 36 |
[GO] |
2024―Mrz―01 |
Marine-Derived Bioactive Metabolites as a Potential Therapeutic Intervention in Managing Viral Diseases: Insights from the SARS-CoV-2 In Silico and Pre-Clinical Studies |
Queency N. Okechukwu, Feyisayo O. Adepoju, Osman N. Kanwugu, Parise Adadi, Ángel Serrano-Aroca, Vladimir N. Uversky, Charles Odilichukwu R. Okpala |
| 37 |
[GO] |
2024―Mrz―01 |
Screening for Active Compounds of Acorus calamus against SARS-CoV-2 Viral Protease and Mechanism Prediction |
Yuting Huang, Zhaoxing Li, Yuan Ma, Qianqian Wu, Jianping Kong, Lijuan Zhao, Shunxiang Li, Juan Li |
| 38 |
[GO] |
2024―Feb―27 |
Epidemiological Evaluation of Events Allegedly Attributable to COVID-19 Vaccination: A Cross-Sectional Study in the Brazilian Amazon |
Matheus Sallys Oliveira Silva, Giovanni Moura Sotelo, Franciane de Paula Fernandes, Livia de Aguiar Valentim, Marcelo Silva de Paula, Tatiane Costa Quaresma, Márcia Jeane do Rego Dias, Géssica Aleane Moraes Esquerdo, Waldiney Pires Moraes, Sheyla Mara Silva de Oliveira |
| 39 |
[GO] |
2024―Feb―27 |
Production and Immunogenicity Assessment of LTp50: An Escherichia coli-Made Chimeric Antigen Targeting S1- and S2-Epitopes from the SARS-CoV-2/BA.5 Spike Protein |
Alejandra Wong-Arce, Omar Gonzalez-Ortega, Andrea Romero-Maldonado, Arleth Miranda-López, Mariano García-Soto, Susan Farfán-Castro, Lourdes Betancourt-Mendiola, Samaporn Teeravechyan, Kanjana Srisutthisamphan, Mauricio Comas-García, Karla I. Solís Andrade, Sergio Rosales-Mendoza |
| 40 |
[GO] |
2024―Feb―12 |
Identification of SARS-CoV-2 Main Protease Inhibitors Using Chemical Similarity Analysis Combined with Machine Learning |
Karina Eurídice Juárez-Mercado, Milton Abraham Gómez-Hernández, Juana Salinas-Trujano, Luis Córdova-Bahena, Clara Espitia, Sonia Mayra Pérez-Tapia, José L. Medina-Franco, Marco A. Velasco-Velázquez |
| 41 |
[GO] |
2024―Feb―06 |
COVID-19 Distribution in Pregnancy, Drug Use Patterns and COVID-19 Medication during the Pandemic in Spain: Data from Real-World Electronic Health Records |
Mercedes Mota-Pérez, Consuelo Huerta-Álvarez, Ana Llorente, Lucía Cea-Soriano |
| 42 |
[GO] |
2024―Feb―05 |
Identification of Factors Associated with Mortality in the Elderly Population with SARS-CoV-2 Infection: Results from a Longitudinal Observational Study from Romania |
Victoria Birlutiu, Bogdan Neamtu, Rares-Mircea Birlutiu |
| 43 |
[GO] |
2024―Feb―02 |
Discovery of Pyrano[2,3-c]pyrazole Derivatives as Novel Potential Human Coronavirus Inhibitors: Design, Synthesis, In Silico, In Vitro, and ADME Studies |
Abdou K. Allayeh, Aliaa H. El-boghdady, Mohamed A. Said, Mahmoud G. A. Saleh, Mohammed T. Abdel-Aal, Mohamed G. Abouelenein |
| 44 |
[GO] |
2024―Jan―30 |
Changes in Epidemiology and Antibiotic Prescription of Influenza: Before and after the Emergence of COVID-19 |
Mihai Aronel Rus, Bogdan Ghițoaica, Andrei Lucian Lazăr, Maria Ancuța Man, Violeta Tincuța Briciu, Monica Iuliana Muntean, Daniel Corneliu Leucuța, Mihaela Sorina Lupșe |
| 45 |
[GO] |
2024―Jan―17 |
Humoral and Cellular Immune Response after Three Doses of Sinopharm [Vero Cell]-Inactivated COVID-19 Vaccine in Combination with SARS-CoV-2 Infection Leads to Hybrid Immunity |
Marija Vukčević, Katarina Šerović, Mateja Despot, Aleksandra Nikolić-Kokić, Aleksandra Vujović, Milan Nikolić, Duško Blagojević, Tanja Jovanović, Dragana Despot |
| 46 |
[GO] |
2023―Dez―26 |
Synthesis and Antiviral Activity of Novel β-D-N4-Hydroxycytidine Ester Prodrugs as Potential Compounds for the Treatment of SARS-CoV-2 and Other Human Coronaviruses |
Elizaveta S. Darnotuk, Andrei E. Siniavin, Natal’ya S. Shastina, Sergey I. Luyksaar, Anna M. Inshakova, Natalia E. Bondareva, Sergey A. Zolotov, Nadezhda L. Lubenec, Anna B. Sheremet, Denis Y. Logunov, Nailya A. Zigangirova, Vladimir A. Gushchin, Alexander L. Gintsburg |
| 47 |
[GO] |
2023―Dez―26 |
Photodynamic Action of Curcumin and Methylene Blue against Bacteria and SARS-CoV-2-A Review |
Siu Kan Law, Albert Wing Nang Leung, Chuanshan Xu |
| 48 |
[GO] |
2023―Dez―19 |
Effects of COVID-19 on the Liver and Mortality in Patients with SARS-CoV-2 Pneumonia Caused by Delta and Non-Delta Variants: An Analysis in a Single Centre |
Monica Muntean, Violeta Briciu, Mihaela Lupse, Doina Colcear, Raul Vlad Macicasan, Agnes Csiszer, Alexandra Manole, Amanda Radulescu |
| 49 |
[GO] |
2023―Okt―20 |
Retrospective Analysis of a Real-Life Use of Tixagevimab-Cilgavimab plus SARS-CoV-2 Antivirals for Treatment of COVID-19 |
Nicolina Capoluongo, Annamaria Mascolo, Francesca Futura Bernardi, Marina Sarno, Valentina Mattera, Giusy di Flumeri, Bruno Pustorino, Micaela Spaterella, Ugo Trama, Annalisa Capuano, Alessandro Perrella |
| 50 |
[GO] |
2023―Okt―17 |
Anti-Viral Activity of Bioactive Molecules of Silymarin against COVID-19 via In Silico Studies |
Chunye Zhang, Yuxiang Sui, Shuai Liu, Ming Yang |
| 51 |
[GO] |
2023―Sep―28 |
Galangal-Cinnamon Spice Mixture Blocks the Coronavirus Infection Pathway through Inhibition of SARS-CoV-2 MPro, Three HCoV-229E Targets; Quantum-Chemical Calculations Support In Vitro Evaluation |
Doaa G. El-Hosari, Wesam M. Hussein, Marwa O. Elgendy, Sara O. Elgendy, Ahmed R. N. Ibrahim, Alzhraa M. Fahmy, Afnan Hassan, Fatma Alzahraa Mokhtar, Modather F. Hussein, Mohamed E. A. Abdelrahim, Eman G. Haggag |
| 52 |
[GO] |
2023―Sep―26 |
Inhibition of SARS-CoV-2 Infection in Vero Cells by Bovine Lactoferrin under Different Iron-Saturation States |
Nathalia S. Alves, Adriana S. Azevedo, Brenda M. Dias, Ingrid S. Horbach, Bruno P. Setatino, Caio B. Denani, Waleska D. Schwarcz, Sheila Maria B. Lima, Sotiris Missailidis, Ana Paula D. Ano Bom, Andréa M. V. Silva, Débora F. Barreto Vieira, Marcos Alexandre N. Silva, Caroline A. Barros, Carlos Alberto M. Carvalho, Rafael B. Gonçalves |
| 53 |
[GO] |
2023―Sep―22 |
Evaluation of Ayush-64 (a Polyherbal Formulation) and Its Ingredients in the Syrian Hamster Model for SARS-CoV-2 Infection Reveals the Preventative Potential of Alstonia scholaris |
Zaigham Abbas Rizvi, Upasna Madan, Manas Ranjan Tripathy, Sandeep Goswami, Shailendra Mani, Amit Awasthi, Madhu Dikshit |
| 54 |
[GO] |
2023―Sep―13 |
Metabolomic Profile, Plasmatic Levels of Losartan and EXP3174, Blood Pressure Control in Hypertensive Patients and Their Correlation with COVID-19 |
Kamila A. Queiroz, Everton P. Vale, Manuel Martín-Pastor, Lílian G. S. Sólon, Francisco F. O. Sousa |
| 55 |
[GO] |
2023―Aug―30 |
Multisystem Inflammatory Syndrome in Children Following COVID-19 Vaccination: A Sex-Stratified Analysis of the VAERS Database Using Brighton Collaboration Criteria |
Valerio Liguori, Alessia Zinzi, Mario Gaio, Consiglia Riccardi, Luigi Di Costanzo, Francesca Gargano, Claudia Carpentieri, Maria D’Elia, Francesca Futura Bernardi, Ugo Trama, Annalisa Capuano, Concetta Rafaniello |
| 56 |
[GO] |
2023―Aug―22 |
Efficacy of Kan Jang® in Patients with Mild COVID-19: A Randomized, Quadruple-Blind, Placebo-Controlled Trial |
Levan Ratiani, Elene Pachkoria, Nato Mamageishvili, Ramaz Shengelia, Areg Hovhannisyan, Alexander Panossian |
| 57 |
[GO] |
2023―Aug―14 |
Honey as a Natural Nutraceutical: Its Combinational Therapeutic Strategies Applicable to Blood Infections-Septicemia, HIV, SARS-CoV-2, Malaria |
Caoimhin Mackin, Divakar Dahiya, Poonam Singh Nigam |
| 58 |
[GO] |
2023―Aug―14 |
Molecular and Structural Aspects of Clinically Relevant Mutations of SARS-CoV-2 RNA-Dependent RNA Polymerase in Remdesivir-Treated Patients |
Carmen Gratteri, Francesca Alessandra Ambrosio, Antonio Lupia, Federica Moraca, Bruno Catalanotti, Giosuè Costa, Maria Bellocchi, Luca Carioti, Romina Salpini, Francesca Ceccherini-Silberstein, Simone La Frazia, Vincenzo Malagnino, Loredana Sarmati, Valentina Svicher, Sharon Bryant, Anna Artese, Stefano Alcaro |
| 59 |
[GO] |
2023―Aug―04 |
Medications Modulating the Acid Sphingomyelinase/Ceramide System and 28-Day Mortality among Patients with SARS-CoV-2: An Observational Study |
Nicolas Hoertel, Katayoun Rezaei, Marina Sánchez-Rico, Alfonso Delgado-Álvarez, Johannes Kornhuber, Erich Gulbins, Mark Olfson, Charles Ouazana-Vedrines, Alexander Carpinteiro, Céline Cougoule, Katrin Anne Becker, Jesús M. Alvarado, Frédéric Limosin |
| 60 |
[GO] |
2023―Aug―03 |
Protective Role of Vitamin K3 on SARS-CoV-2 Structural Protein-Induced Inflammation and Cell Death |
Yixiong Zhan, Duoduo Zha, Hongru Lin, Xianxian Mao, Lingyi Yang, Houda Huang, Zongnan He, Sheng Zhou, Fei Xu, Yisong Qian, Yu Liu |
| 61 |
[GO] |
2023―Jun―26 |
Theory and Practice of Glucocorticoids in COVID-19: Getting to the Heart of the Matter-A Critical Review and Viewpoints |
Francesco Salton, Paola Confalonieri, Gianfranco Umberto Meduri, Lucrezia Mondini, Liliana Trotta, Mariangela Barbieri, Chiara Bozzi, Chiara Torregiani, Selene Lerda, Mattia Bellan, Marco Confalonieri, Barbara Ruaro, Stefano Tavano, Riccardo Pozzan |
| 62 |
[GO] |
2023―Jun―20 |
Metformin Therapy Changes Gut Microbiota Alpha-Diversity in COVID-19 Patients with Type 2 Diabetes: The Role of SARS-CoV-2 Variants and Antibiotic Treatment |
Pavlo Petakh, Iryna Kamyshna, Valentyn Oksenych, Denis Kainov, Aleksandr Kamyshnyi |
| 63 |
[GO] |
2023―Jun―08 |
Sex-Related Differences in the Pharmacological Response in SARS-CoV-2 Infection, Dyslipidemia, and Diabetes Mellitus: A Narrative Review |
Adelina Lombrea, Mirabela Romanescu, Narcisa Jianu, Minodora Andor, Maria Suciu, Dana Emilia Man, Corina Danciu, Cristina Adriana Dehelean, Valentina Buda |
| 64 |
[GO] |
2023―Jun―05 |
A Tale of Two Proteases: MPro and TMPRSS2 as Targets for COVID-19 Therapies |
Barbara Farkaš, Marco Minneci, Matas Misevicius, Isabel Rozas |
| 65 |
[GO] |
2023―Mai―29 |
Phase II, Double-Blinded, Randomized, Placebo-Controlled Clinical Trial Investigating the Efficacy of Mebendazole in the Management of Symptomatic COVID-19 Patients |
Mohamed El-Tanani, Khaled Abdul-Aziz Ahmed, Ashok K. Shakya, Wesam G. Ammari, Abdel-Elah Al-Shudifat |
| 66 |
[GO] |
2023―Mai―10 |
Immune-Mediated Organ-Specific Reactions to COVID-19 Vaccines: A Retrospective Descriptive Study |
Carmen Ruiz-Fernández, Ricardo Cuesta, Susana Martín-López, Javier Guijarro, Arturo López Gómez de las Huertas, Mikel Urroz, Laura Miguel-Berenguel, Miguel González-Muñoz, Elena Ramírez |
| 67 |
[GO] |
2023―Mai―10 |
Molnupiravir, Nirmatrelvir/Ritonavir, or Sotrovimab for High-Risk COVID-19 Patients Infected by the Omicron Variant: Hospitalization, Mortality, and Time until Negative Swab Test in Real Life |
Luca Cegolon, Riccardo Pol, Omar Simonetti, Francesca Larese Filon, Roberto Luzzati |
| 68 |
[GO] |
2023―Apr―21 |
Pentoxifylline Effects on Hospitalized COVID-19 Patients with Cytokine Storm Syndrome: A Randomized Clinical Trial |
Rania M. Sarhan, Ahmed E. Altyar, Ahmed Essam Abou Warda, Yasmine Mohamed Saied, Haytham Soliman Ghareeb Ibrahim, Mona F. Schaalan, Shaimaa Fathy, Neven Sarhan, Marian S. Boshra |
| 69 |
[GO] |
2023―Apr―18 |
Design of Potent Inhibitors Targeting the Main Protease of SARS-CoV-2 Using QSAR Modeling, Molecular Docking, and Molecular Dynamics Simulations |
Mehdi Oubahmane, Ismail Hdoufane, Christelle Delaite, Adlane Sayede, Driss Cherqaoui, Achraf El Allali |
| 70 |
[GO] |
2023―Apr―14 |
N-Acetyl Cysteine Restores the Diminished Activity of the Antioxidant Enzymatic System Caused by SARS-CoV-2 Infection: Preliminary Findings |
María Elena Soto, Linaloe Manzano-Pech, Adrían Palacios-Chavarría, Rafael Ricardo Valdez-Vázquez, Verónica Guarner-Lans, Israel Pérez-Torres |
| 71 |
[GO] |
2023―Apr―14 |
Autochthonous Peruvian Natural Plants as Potential SARS-CoV-2 Mpro Main Protease Inhibitors |
Maria Nuria Peralta-Moreno, Vanessa Anton-Muñoz, David Ortega-Alarcon, Ana Jimenez-Alesanco, Sonia Vega, Olga Abian, Adrian Velazquez-Campoy, Timothy M. Thomson, José Manuel Granadino-Roldán, Claudia Machicado, Jaime Rubio-Martinez |
| 72 |
[GO] |
2023―Apr―12 |
Maintenance of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients after 1273-mRNA SARS-CoV-2 Vaccination |
Maria Gonzalez-Perez, Jana Baranda, Marcos J. Berges-Buxeda, Patricia Conde, Mayte Pérez-Olmeda, Daniel Lozano-Ojalvo, Carmen Cámara, Maria del Rosario Llópez-Carratalá, Emilio Gonzalez-Parra, Pilar Portolés, Alberto Ortiz, Jose Portoles, Jordi Ochando |
| 73 |
[GO] |
2023―Mrz―21 |
Phenylpyrazolone-1,2,3-triazole Hybrids as Potent Antiviral Agents with Promising SARS-CoV-2 Main Protease Inhibition Potential |
Arafa Musa, Hamada S. Abulkhair, Ateyatallah Aljuhani, Nadjet Rezki, Mohamed A. Abdelgawad, Khaled Shalaby, Ahmed H. El-Ghorab, Mohamed R. Aouad |
| 74 |
[GO] |
2023―Feb―15 |
In Silico Screening of Drugs That Target Different Forms of E Protein for Potential Treatment of COVID-19 |
Gema Lizbeth Ramírez Salinas, Alejandro López Rincón, Jazmín García Machorro, José Correa Basurto, Marlet Martínez Archundia |
| 75 |
[GO] |
2023―Feb―14 |
Copper(II) Chelates of Schiff Bases Enriched with Aliphatic Fragments: Synthesis, Crystal Structure, In Silico Studies of ADMET Properties and a Potency against a Series of SARS-CoV-2 Proteins |
Elizaveta V. Panova, Julia K. Voronina, Damir A. Safin |
| 76 |
[GO] |
2023―Jan―30 |
Discovery of Polyphenolic Natural Products as SARS-CoV-2 Mpro Inhibitors for COVID-19 |
Nadine Krüger, Thales Kronenberger, Hang Xie, Cheila Rocha, Stefan Pöhlmann, Haixia Su, Yechun Xu, Stefan A. Laufer, Thanigaimalai Pillaiyar |
| 77 |
[GO] |
2023―Jan―16 |
Protective Effect of Vitamin D Supplementation on COVID-19-Related Intensive Care Hospitalization and Mortality: Definitive Evidence from Meta-Analysis and Trial Sequential Analysis |
Christiano Argano, Raffaella Mallaci Bocchio, Giuseppe Natoli, Salvatore Scibetta, Marika Lo Monaco, Salvatore Corrao |
| 78 |
[GO] |
2022―Dez―19 |
The Hidden Pandemic of COVID-19-Induced Organizing Pneumonia |
Evgeny Bazdyrev, Maria Panova, Valeria Zherebtsova, Alexandra Burdenkova, Ivan Grishagin, Fedor Novikov, Vladimir Nebolsin |
| 79 |
[GO] |
2022―Dez―05 |
Update on COVID-19 Therapy in Pediatric Age |
Susanna Esposito, Giovanni Autore, Alberto Argentiero, Greta Ramundo, Serafina Perrone, Nicola Principi |
| 80 |
[GO] |
2022―Nov―28 |
Cardiovascular Adverse Events Associated with Monoclonal Antibody Products in Patients with COVID-19 |
Jingrui Zou, Fuyuan Jing |
| 81 |
[GO] |
2022―Nov―24 |
Analyzing the Difference in the Length of Stay (LOS) in Moderate to Severe COVID-19 Patients Receiving Hydroxychloroquine or Favipiravir |
Bandar Alosaimi, Huda M. Alshanbari, Muath Alturaiqy, Halah Z. AlRawi, Saad Alamri, Asma Albujaidy, Aljawharah Bin Sabaan, Ahmed A. Alrashed, Ahmad Alamer, Fayez Alghofaili, Khaled Al-Duraymih, Abdulaziz J. Alshalani, Wael Alturaiki |
| 82 |
[GO] |
2022―Nov―22 |
SARS-CoV-2 Inhibitors Identified by Phenotypic Analysis of a Collection of Viral RNA-Binding Molecules |
Alvaro Simba-Lahuasi, Ángel Cantero-Camacho, Romel Rosales, Briana Lynn McGovern, M. Luis Rodríguez, Vicente Marchán, Kris M. White, Adolfo García-Sastre, José Gallego |
| 83 |
[GO] |
2022―Nov―11 |
Can Essential Oils Provide an Alternative Adjuvant Therapy for COVID-19 Infections and Pain Management at the Same Time? |
Roxana Damiescu, David Y. W. Lee, Thomas Efferth |
| 84 |
[GO] |
2022―Nov―08 |
Potential Therapeutic Benefits of Metformin Alone and in Combination with Sitagliptin in the Management of Type 2 Diabetes Patients with COVID-19 |
Hayder M. Al-Kuraishy, Ali I. Al-Gareeb, Sarah M. Albogami, Sabatier Jean-Marc, Eman Hassan Nadwa, Amin A. Hafiz, Walaa A. Negm, Marwa Kamal, Mohammed Al-Jouboury, Engy Elekhnawy, Gaber El-Saber Batiha, Michel De Waard |
| 85 |
[GO] |
2022―Okt―30 |
Hybrid Approach to Identifying Druglikeness Leading Compounds against COVID-19 3CL Protease |
Imra Aqeel, Muhammad Bilal, Abdul Majid, Tuba Majid |
| 86 |
[GO] |
2022―Okt―24 |
An Algae-Made RBD from SARS-CoV-2 Is Immunogenic in Mice |
Dania O. Govea-Alonso, Ashwini Malla, Omayra C. Bolaños-Martínez, Sornkanok Vimolmangkang, Sergio Rosales-Mendoza |
| 87 |
[GO] |
2022―Sep―26 |
Pelargonium sidoides Root Extract: Simultaneous HPLC Separation, Determination, and Validation of Selected Biomolecules and Evaluation of SARS-CoV2 Inhibitory Activity |
Manal A. Alossaimi, May A. Alzeer, Fatma M. Abdel Bar, Mai H. ElNaggar |
| 88 |
[GO] |
2022―Aug―31 |
Broad-Spectrum Small-Molecule Inhibitors of the SARS-CoV-2 Spike-ACE2 Protein-Protein Interaction from a Chemical Space of Privileged Protein Binders |
Sung-Ting Chuang, Peter Buchwald |
| 89 |
[GO] |
2022―Aug―30 |
Repurposing Potential of the Antiparasitic Agent Ivermectin for the Treatment and/or Prophylaxis of COVID-19 |
Hoda Awad, Basmala Hassan, Sara Dweek, Yasmeen Aboelata, Mutasem Rawas-Qalaji, Iman Saad Ahmed |
| 90 |
[GO] |
2022―Aug―30 |
Real-World Use of Molnupiravir in the Treatment of Outpatients with SARS-CoV-2 Infection-A Patient Profile Based on the Experience of a Tertiary Infectious Disease Center |
Anca Streinu-Cercel, Victor Daniel Miron, Alina Alexandra Oană, Mădălina Irimia, Ramona Ștefania Popescu, Ioana Andreea Dărămuș, Maria Magdalena Moțoi, Gabriela Jana Ceapraga, Oana Săndulescu |
| 91 |
[GO] |
2022―Aug―26 |
Quercetin in the Prevention and Treatment of Coronavirus Infections: A Focus on SARS-CoV-2 |
Amin Gasmi, Pavan Kumar Mujawdiya, Roman Lysiuk, Mariia Shanaida, Massimiliano Peana, Asma Gasmi Benahmed, Nataliya Beley, Nadiia Kovalska, Geir Bjørklund |
| 92 |
[GO] |
2022―Aug―25 |
Plant Metabolites as SARS-CoV-2 Inhibitors Candidates: In Silico and In Vitro Studies |
Alberto Jorge Oliveira Lopes, Gustavo Pereira Calado, Yuri Nascimento Fróes, Sandra Alves de Araújo, Lucas Martins França, Antonio Marcus de Andrade Paes, Sebastião Vieira de Morais, Cláudia Quintino da Rocha, Cleydlenne Costa Vasconcelos |
| 93 |
[GO] |
2022―Aug―19 |
A Versatile Class of 1,4,4-Trisubstituted Piperidines Block Coronavirus Replication In Vitro |
Sonia De Castro, Annelies Stevaert, Miguel Maldonado, Adrien Delpal, Julie Vandeput, Benjamin Van Loy, Cecilia Eydoux, Jean-Claude Guillemot, Etienne Decroly, Federico Gago, Bruno Canard, Maria-Jose Camarasa, Sonsoles Velázquez, Lieve Naesens |
| 94 |
[GO] |
2022―Aug―18 |
Efficacy of Kan Jang® in Patients with Mild COVID-19: Interim Analysis of a Randomized, Quadruple-Blind, Placebo-Controlled Trial |
Levan Ratiani, Elene Pachkoria, Nato Mamageishvili, Ramaz Shengelia, Areg Hovhannisyan, Alexander Panossian |
| 95 |
[GO] |
2022―Aug―11 |
Search for Novel Potent Inhibitors of the SARS-CoV-2 Papain-like Enzyme: A Computational Biochemistry Approach |
Manuel I. Osorio, Osvaldo Yáñez, Mauricio Gallardo, Matías Zuñiga-Bustos, Jorge Mulia-Rodríguez, Roberto López-Rendón, Olimpo García-Beltrán, Fernando González-Nilo, José M. Pérez-Donoso |
| 96 |
[GO] |
2022―Aug―04 |
Identification of a Dual Inhibitor of Secreted Phospholipase A2 (GIIA sPLA2) and SARS-CoV-2 Main Protease |
Maria A. Theodoropoulou, Giorgos S. Koutoulogenis, Linlin Zhang, Ifigeneia Akrani, Emmanuel Mikros, Rolf Hilgenfeld, George Kokotos |
| 97 |
[GO] |
2022―Jul―25 |
Impaired Vitamin D Metabolism in Hospitalized COVID-19 Patients |
Alexandra Povaliaeva, Viktor Bogdanov, Ekaterina Pigarova, Larisa Dzeranova, Nino Katamadze, Natalya Malysheva, Vitaliy Ioutsi, Larisa Nikankina, Liudmila Rozhinskaya, Natalia Mokrysheva |
| 98 |
[GO] |
2022―Jul―14 |
Synthesis and Biological Evaluation of Imadazo[1,2-a]pyrazines as Anticancer and Antiviral Agents through Inhibition of CDK9 and Human Coronavirus |
Aisha A. Alsfouk, Hanan M. Alshibl, Bshra A. Alsfouk, Najla A. Altwaijry, Ebtehal S. Al-Abdullah |
| 99 |
[GO] |
2022―Jul―05 |
Optimization of 2-Aminoquinazolin-4-(3H)-one Derivatives as Potent Inhibitors of SARS-CoV-2: Improved Synthesis and Pharmacokinetic Properties |
Young Sup Shin, Jun Young Lee, Sangeun Jeon, Jung-Eun Cho, Subeen Myung, Min Seong Jang, Seungtaek Kim, Jong Hwan Song, Hyoung Rae Kim, Hyeung-geun Park, Lak Shin Jeong, Chul Min Park |
| 100 |
[GO] |
2022―Jun―27 |
The Potential Complementary Role of Using Chinese Herbal Medicine with Western Medicine in Treating COVID-19 Patients: Pharmacology Network Analysis |
Yi-Chin Lu, Liang-Wei Tseng, Yu-Chieh Huang, Ching-Wei Yang, Yu-Chun Chen, Hsing-Yu Chen |
| 101 |
[GO] |
2022―Jun―24 |
Biologics in COVID-19 So Far: Systematic Review |
Milton Arias, Henry Oliveros, Sharon Lechtig, Rosa-Helena Bustos |
| 102 |
[GO] |
2022―Jun―17 |
Effect of Norelgestromin and Ethinylestradiol in Transdermal Patches on the Clinical Outcomes and Biochemical Parameters of COVID-19 Patients: A Clinical Trial Pilot Study |
Cortés-Algara Alfredo, Cárdenas-Rodríguez Noemí, Reyes-Long Samuel, Ortega-Cuellar Daniel, Ruz-Barros Rodrigo, Mondragón-Terán Paul, Escamilla-Tilch Mónica, Correa-Basurto José, Lara-Padilla Eleazar, Alfaro-Rodríguez Alfonso, Cortes-Altamirano José Luis, Bandala Cindy |
| 103 |
[GO] |
2022―Jun―14 |
Discovery of Triple Inhibitors of Both SARS-CoV-2 Proteases and Human Cathepsin L |
Ittipat Meewan, Jacob Kattoula, Julius Y. Kattoula, Danielle Skinner, Pavla Fajtová, Miriam A. Giardini, Brendon Woodworth, James H. McKerrow, Jair Lage de Siqueira-Neto, Anthony J. O’Donoghue, Ruben Abagyan |
| 104 |
[GO] |
2022―Jun―14 |
Computational Investigations of Traditional Chinese Medicinal Compounds against the Omicron Variant of SARS-CoV-2 to Rescue the Host Immune System |
Ziad Tareq Naman, Salim Kadhim, Zahraa J. K. Al-Isawi, Christopher J. Butch, Ziyad Tariq Muhseen |
| 105 |
[GO] |
2022―Jun―13 |
Will the Use of Pharmacogenetics Improve Treatment Efficiency in COVID-19? |
Beata Franczyk, Jacek Rysz, Jarosław Miłoński, Tomasz Konecki, Magdalena Rysz-Górzyńska, Anna Gluba-Brzózka |
| 106 |
[GO] |
2022―Jun―04 |
Protocetraric and Salazinic Acids as Potential Inhibitors of SARS-CoV-2 3CL Protease: Biochemical, Cytotoxic, and Computational Characterization of Depsidones as Slow-Binding Inactivators |
Lorenza Fagnani, Lisaurora Nazzicone, Pierangelo Bellio, Nicola Franceschini, Donatella Tondi, Andrea Verri, Sabrina Petricca, Roberto Iorio, Gianfranco Amicosante, Mariagrazia Perilli, Giuseppe Celenza |
| 107 |
[GO] |
2022―Jun―01 |
Analgesics Induce Alterations in the Expression of SARS-CoV-2 Entry and Arachidonic-Acid-Metabolizing Genes in the Mouse Lungs |
Fatima Khirfan, Yazun Jarrar, Tariq Al-Qirim, Khang Wen Goh, Qais Jarrar, Chrismawan Ardianto, Mohammad Awad, Hamzeh J. Al-Ameer, Wajdy Al-Awaida, Said Moshawih, Long Chiau Ming |
| 108 |
[GO] |
2022―Mai―30 |
Accurate Mass Identification of an Interfering Water Adduct and Strategies in Development and Validation of an LC-MS/MS Method for Quantification of MPI8, a Potent SARS-CoV-2 Main Protease Inhibitor, in Rat Plasma in Pharmacokinetic Studies |
Yang Wang, Huan Xie, Yugendar R. Alugubelli, Yuying Ma, Shiqing Xu, Jing Ma, Wenshe R. Liu, Dong Liang |
| 109 |
[GO] |
2022―Mai―30 |
European Safety Analysis of mRNA and Viral Vector COVID-19 Vaccines on Glucose Metabolism Events |
Gabriella di Mauro, Annamaria Mascolo, Miriam Longo, Maria Ida Maiorino, Lorenzo Scappaticcio, Giuseppe Bellastella, Katherine Esposito, Annalisa Capuano |
| 110 |
[GO] |
2022―Mai―21 |
Safety of Short-Term Treatments with Oral Chloroquine and Hydroxychloroquine in Patients with and without COVID-19: A Systematic Review |
Sergio Marin, Alba Martin Val, Maite Bosch Peligero, Cristina Rodríguez-Bernuz, Ariadna Pérez-Ricart, Laia Vilaró Vilaró Jaques, Roger Paredes, Josep Roca, Carles Quiñones |
| 111 |
[GO] |
2022―Mai―19 |
Methylene Blue Is a Nonspecific Protein-Protein Interaction Inhibitor with Potential for Repurposing as an Antiviral for COVID-19 |
Sung-Ting Chuang, Henrietta Papp, Anett Kuczmog, Rebecca Eells, Jose M. Condor Capcha, Lina A. Shehadeh, Ferenc Jakab, Peter Buchwald |
| 112 |
[GO] |
2022―Mai―18 |
Discovery of Natural Lead Compound from Dendrobium sp. against SARS-CoV-2 Infection |
Jutamas Jiaranaikulwanitch, Wipawadee Yooin, Nopporn Chutiwitoonchai, Worathat Thitikornpong, Boonchoo Sritularak, Pornchai Rojsitthisak, Opa Vajragupta |
| 113 |
[GO] |
2022―Mai―17 |
Immunosuppressant Therapies in COVID-19: Is the TNF Axis an Alternative? |
Yadira Palacios, Leslie Chavez-Galan |
| 114 |
[GO] |
2022―Mai―17 |
Integrin/TGF-β1 Inhibitor GLPG-0187 Blocks SARS-CoV-2 Delta and Omicron Pseudovirus Infection of Airway Epithelial Cells In Vitro, Which Could Attenuate Disease Severity |
Kelsey E. Huntington, Lindsey Carlsen, Eui-Young So, Matthias Piesche, Olin Liang, Wafik S. El-Deiry |
| 115 |
[GO] |
2022―Apr―28 |
Design, Synthesis and Evaluation of Fused Bicyclo[2.2.2]octene as a Potential Core Scaffold for the Non-Covalent Inhibitors of SARS-CoV-2 3CLpro Main Protease |
Barbara Herlah, Andrej Hoivik, Luka Jamšek, Katja Valjavec, Norio Yamamoto, Tyuji Hoshino, Krištof Kranjc, Andrej Perdih |
| 116 |
[GO] |
2022―Apr―28 |
Design of D-Amino Acids SARS-CoV-2 Main Protease Inhibitors Using the Cationic Peptide from Rattlesnake Venom as a Scaffold |
Raphael J. Eberle, Ian Gering, Markus Tusche, Philipp N. Ostermann, Lisa Müller, Ortwin Adams, Heiner Schaal, Danilo S. Olivier, Marcos S. Amaral, Raghuvir K. Arni, Dieter Willbold, Mônika A. Coronado |
| 117 |
[GO] |
2022―Apr―26 |
Disentangling a Thorny Issue: Myocarditis and Pericarditis Post COVID-19 and Following mRNA COVID-19 Vaccines |
Concetta Rafaniello, Mario Gaio, Alessia Zinzi, Maria Giuseppa Sullo, Valerio Liguori, Marialuisa Ferraro, Fiorella Petronzelli, Patrizia Felicetti, Pasquale Marchione, Anna Rosa Marra, Francesco Rossi, Antonella De Angelis, Annalisa Capuano |
| 118 |
[GO] |
2022―Apr―26 |
Hypericum perforatum and Its Ingredients Hypericin and Pseudohypericin Demonstrate an Antiviral Activity against SARS-CoV-2 |
Fakry F. Mohamed, Darisuren Anhlan, Michael Schöfbänker, André Schreiber, Nica Classen, Andreas Hensel, Georg Hempel, Wolfgang Scholz, Joachim Kühn, Eike R. Hrincius, Stephan Ludwig |
| 119 |
[GO] |
2022―Apr―03 |
Antiviral Activity of Repurposing Ivermectin against a Panel of 30 Clinical SARS-CoV-2 Strains Belonging to 14 Variants |
Océane Delandre, Mathieu Gendrot, Priscilla Jardot, Marion Le Bideau, Manon Boxberger, Céline Boschi, Isabelle Fonta, Joel Mosnier, Sébastien Hutter, Anthony Levasseur, Bernard La Scola, Bruno Pradines |
| 120 |
[GO] |
2022―Mrz―25 |
Targeting Viral Ion Channels: A Promising Strategy to Curb SARS-CoV-2 |
Anamika Singh, Isaiah T. Arkin |
| 121 |
[GO] |
2022―Mrz―22 |
Association of Amlodipine with the Risk of In-Hospital Death in Patients with COVID-19 and Hypertension: A Reanalysis on 184 COVID-19 Patients with Hypertension |
Gwenolé Loas, Philippe Van de Borne, Gil Darquennes, Pascal Le Corre |
| 122 |
[GO] |
2022―Mrz―21 |
Use of Early Donated COVID-19 Convalescent Plasma Is Optimal to Preserve the Integrity of Lymphatic Endothelial Cells |
Nada Amri, Rémi Bégin, Nolwenn Tessier, Laurent Vachon, Louis Villeneuve, Philippe Bégin, Renée Bazin, Lionel Loubaki, Catherine Martel |
| 123 |
[GO] |
2022―Mrz―21 |
One-Pot Synthesis and Molecular Modeling Studies of New Bioactive Spiro-Oxindoles Based on Uracil Derivatives as SARS-CoV-2 Inhibitors Targeting RNA Polymerase and Spike Glycoprotein |
Samar A. El-Kalyoubi, Ahmed Ragab, Ola A. Abu Abu Ali, Yousry A. Ammar, Mohamed G. Seadawy, Aya Ahmed, Eman A. Fayed |
| 124 |
[GO] |
2022―Mrz―14 |
Efficacy of Adaptogens in Patients with Long COVID-19: A Randomized, Quadruple-Blind, Placebo-Controlled Trial |
Irina Karosanidze, Ushangi Kiladze, Nino Kirtadze, Mikhail Giorgadze, Nana Amashukeli, Nino Parulava, Neli Iluridze, Nana Kikabidze, Nana Gudavadze, Lali Gelashvili, Vazha Koberidze, Eka Gigashvili, Natela Jajanidze, Naira Latsabidze, Nato Mamageishvili, Ramaz Shengelia, Areg Hovhannisyan, Alexander Panossian |
| 125 |
[GO] |
2022―Mrz―09 |
COVID-19 and Seasonal Influenza Vaccination: Cross-Protection, Co-Administration, Combination Vaccines, and Hesitancy |
Alexander Domnich, Andrea Orsi, Carlo-Simone Trombetta, Giulia Guarona, Donatella Panatto, Giancarlo Icardi |
| 126 |
[GO] |
2022―Mrz―09 |
From Biomedical Applications of Alginate towards CVD Implications Linked to COVID-19 |
Angela Spoială, Cornelia-Ioana Ilie, Denisa Ficai, Anton Ficai, Ecaterina Andronescu |
| 127 |
[GO] |
2022―Mrz―03 |
Vitamin D Status and Immune Response in Hospitalized Patients with Moderate and Severe COVID-19 |
Tatiana L. Karonova, Igor V. Kudryavtsev, Ksenia A. Golovatyuk, Arthur D. Aquino, Olga V. Kalinina, Alena T. Chernikova, Ekaterina K. Zaikova, Denis A. Lebedev, Ekaterina S. Bykova, Alexey S. Golovkin, Evgeny V. Shlyakhto |
| 128 |
[GO] |
2022―Feb―22 |
Population Pharmacokinetics of Hydroxychloroquine and 3 Metabolites in COVID-19 Patients and Pharmacokinetic/Pharmacodynamic Application |
Jean Claude Alvarez, Benjamin Davido, Pierre Moine, Isabelle Etting, Djillali Annane, Islam Amine Larabi, Nicolas Simon |
| 129 |
[GO] |
2022―Feb―21 |
Effects of Ultramicronized Palmitoylethanolamide (um-PEA) in COVID-19 Early Stages: A Case-Control Study |
Maria Albanese, Giulia Marrone, Agostino Paolino, Manuela Di Di Lauro, Francesca Di Di Daniele, Carlo Chiaramonte, Cartesio D’Agostini, Annalisa Romani, Alessandro Cavaliere, Cristina Guerriero, Andrea Magrini, Nicola Biagio Mercuri, Nicola Di Di Daniele, Annalisa Noce |
| 130 |
[GO] |
2022―Feb―07 |
Mineralocorticoid Receptor Antagonist (Potassium Canrenoate) Does Not Influence Outcome in the Treatment of COVID-19-Associated Pneumonia and Fibrosis-A Randomized Placebo Controlled Clinical Trial |
Katarzyna Kotfis, Igor Karolak, Kacper Lechowicz, Małgorzata Zegan-Barańska, Agnieszka Pikulska, Paulina Niedźwiedzka-Rystwej, Miłosz Kawa, Jerzy Sieńko, Aleksandra Szylińska, Magda Wiśniewska |
| 131 |
[GO] |
2022―Feb―07 |
Dementia and COVID-19: A Case Report and Literature Review on Pain Management |
Damiana Scuteri, Marianna Contrada, Paolo Tonin, Maria Tiziana Corasaniti, Pierluigi Nicotera, Giacinto Bagetta |
| 132 |
[GO] |
2022―Feb―02 |
Re-Exploring the Ability of Common Docking Programs to Correctly Reproduce the Binding Modes of Non-Covalent Inhibitors of SARS-CoV-2 Protease Mpro |
Davide Bassani, Matteo Pavan, Giovanni Bolcato, Mattia Sturlese, Stefano Moro |
| 133 |
[GO] |
2022―Jan―29 |
Novel Small-Molecule Inhibitors of the SARS-CoV-2 Spike Protein Binding to Neuropilin 1 |
Anja Kolarič, Marko Jukič, Urban Bren |
| 134 |
[GO] |
2022―Jan―28 |
Exploring Toxins for Hunting SARS-CoV-2 Main Protease Inhibitors: Molecular Docking, Molecular Dynamics, Pharmacokinetic Properties, and Reactome Study |
Mahmoud A. A. Ibrahim, Alaa H. M. Abdelrahman, Laila A. Jaragh-Alhadad, Mohamed A. M. Atia, Othman R. Alzahrani, Muhammad Naeem Ahmed, Moustafa Sherief Moustafa, Mahmoud E. S. Soliman, Ahmed M. Shawky, Paul W. Paré, Mohamed-Elamir F. Hegazy, Peter A. Sidhom |
| 135 |
[GO] |
2022―Jan―24 |
Antiviral Effects of Artemisinin and Its Derivatives against SARS-CoV-2 Main Protease: Computational Evidences and Interactions with ACE2 Allelic Variants |
Riadh Badraoui, Mongi Saoudi, Walid S. Hamadou, Salem Elkahoui, Arif J. Siddiqui, Jahoor M. Alam, Arshad Jamal, Mohd Adnan, Abdel M. E. Suliemen, Mousa M. Alreshidi, Dharmendra K. Yadav, Houcine Naïli, Hmed Ben-Nasr |
| 136 |
[GO] |
2022―Jan―10 |
A Case-Control of Patients with COVID-19 to Explore the Association of Previous Hospitalisation Use of Medication on the Mortality of COVID-19 Disease: A Propensity Score Matching Analysis |
Jaime Monserrat Villatoro, Gina Mejía-Abril, Lucía Díaz García, Pablo Zubiaur, María Jiménez González, Guillermo Fernandez Jimenez, Inés Cancio, José Ramón Arribas, Carmen Suarez Fernández, Jesús Mingorance, Julio García Rodríguez, José Ramón Villagrasa Ferrer, Antonio J. Carcas, Jesús Frías, Francisco Abad-Santos, Alberto M. Borobia, Elena Ramírez |
| 137 |
[GO] |
2021―Dez―27 |
Clinical Management of COVID-19 in Cancer Patients with the STAT3 Inhibitor Silibinin |
Joaquim Bosch-Barrera, Ariadna Roqué, Eduard Teixidor, Maria Carmen Carmona-Garcia, Aina Arbusà, Joan Brunet, Begoña Martin-Castillo, Elisabet Cuyàs, Sara Verdura, Javier A. Menendez |
| 138 |
[GO] |
2021―Dez―27 |
Atazanavir Is a Competitive Inhibitor of SARS-CoV-2 Mpro, Impairing Variants Replication In Vitro and In Vivo |
Otávio Augusto Chaves, Carolina Q. Sacramento, André C. Ferreira, Mayara Mattos, Natalia Fintelman-Rodrigues, Jairo R. Temerozo, Leonardo Vazquez, Douglas Pereira Pinto, Gabriel P. E. da Silveira, Laís Bastos da Fonseca, Heliana Martins Pereira, Aluana Santana Carlos, Joana C. d’Avila, João P. B. Viola, Robson Q. Monteiro, Patrícia T. Bozza, Hugo Caire Castro-Faria-Neto, Thiago Moreno L. Souza |
| 139 |
[GO] |
2021―Dez―20 |
Quality Assessment of Investigational Medicinal Products in COVID-19 Clinical Trials: One Year of Activity at the Clinical Trials Office |
Diego Alejandro Dri, Giulia Praticò, Elisa Gaucci, Carlotta Marianecci, Donatella Gramaglia |
| 140 |
[GO] |
2021―Dez―20 |
Inhibition Ability of Natural Compounds on Receptor-Binding Domain of SARS-CoV2: An In Silico Approach |
Miroslava Nedyalkova, Mahdi Vasighi, Subrahmanyam Sappati, Anmol Kumar, Sergio Madurga, Vasil Simeonov |
| 141 |
[GO] |
2021―Dez―17 |
Promising Antiviral Activity of Agrimonia pilosa Phytochemicals against Severe Acute Respiratory Syndrome Coronavirus 2 Supported with In Vivo Mice Study |
Nashwah G. M. Attallah, Aya H. El-Kadem, Walaa A. Negm, Engy Elekhnawy, Thanaa A. El-Masry, Elshaymaa I. Elmongy, Najla Altwaijry, Ashwag S. Alanazi, Gadah Abdulaziz Al-Hamoud, Amany E. Ragab |
| 142 |
[GO] |
2021―Dez―07 |
Monoclonal Antibodies against SARS-CoV-2: Current Scenario and Future Perspectives |
Eugenia Quiros-Roldan, Silvia Amadasi, Isabella Zanella, Melania Degli Antoni, Samuele Storti, Giorgio Tiecco, Francesco Castelli |
| 143 |
[GO] |
2021―Dez―03 |
Antirheumatic Drugs against COVID-19 from the Perspective of Rheumatologists |
Mai Kawazoe, Mari Kihara, Toshihiro Nanki |
| 144 |
[GO] |
2021―Dez―01 |
Teicoplanin-A New Use for an Old Drug in the COVID-19 Era? |
Vladimir Vimberg |
| 145 |
[GO] |
2021―Dez―01 |
Computational and In Vitro Experimental Investigations Reveal Anti-Viral Activity of Licorice and Glycyrrhizin against Severe Acute Respiratory Syndrome Coronavirus 2 |
Ahmed M. Tolah, Lamya M. Altayeb, Thamir A. Alandijany, Vivek Dhar Dwivedi, Sherif A. El-Kafrawy, Esam I. Azhar |
| 146 |
[GO] |
2021―Dez―01 |
Discovery of SARS-CoV-2 Nsp14 and Nsp16 Methyltransferase Inhibitors by High-Throughput Virtual Screening |
Raitis Bobrovs, Iveta Kanepe, Nauris Narvaiss, Liene Patetko, Gints Kalnins, Mihails Sisovs, Anna L. Bula, Solveiga Grinberga, Martins Boroduskis, Anna Ramata-Stunda, Nils Rostoks, Aigars Jirgensons, Kaspars Tars, Kristaps Jaudzems |
| 147 |
[GO] |
2021―Nov―17 |
Brief on Recent Application of Liposomal Vaccines for Lower Respiratory Tract Viral Infections: From Influenza to COVID-19 Vaccines |
Mohamed Ahmed Attia, Ebtessam Ahmed Essa, Toka Tarek Elebyary, Ahmed Mostafa Faheem, Amal Ali Elkordy |
| 148 |
[GO] |
2021―Nov―12 |
An Evaluation of the Potential of Essential Oils against SARS-CoV-2 from In Silico Studies through the Systematic Review Using a Chemometric Approach |
Luiz Torres Neto, Maria Lúcia Guerra Monteiro, Diego Galvan, Carlos Adam Conte-Junior |
| 149 |
[GO] |
2021―Nov―12 |
Investigation of Thiocarbamates as Potential Inhibitors of the SARS-CoV-2 Mpro |
Katarzyna Papaj, Patrycja Spychalska, Katarzyna Hopko, Patryk Kapica, Andre Fisher, Markus A. Lill, Weronika Bagrowska, Jakub Nowak, Katarzyna Szleper, Martin Smieško, Anna Kasprzycka, Artur Góra |
| 150 |
[GO] |
2021―Nov―09 |
Regulation of m6A Methylation as a New Therapeutic Option against COVID-19 |
Carla Zannella, Luca Rinaldi, Giovanni Boccia, Annalisa Chianese, Ferdinando Carlo Sasso, Francesco De Caro, Gianluigi Franci, Massimiliano Galdiero |
| 151 |
[GO] |
2021―Nov―02 |
Natural Apocarotenoids and Their Synthetic Glycopeptide Conjugates Inhibit SARS-CoV-2 Replication |
Ilona Bereczki, Henrietta Papp, Anett Kuczmog, Mónika Madai, Veronika Nagy, Attila Agócs, Gyula Batta, Márton Milánkovits, Eszter Ostorházi, Ana Mitrović, Janko Kos, Áron Zsigmond, István Hajdú, Zsolt Lőrincz, Dávid Bajusz, György Miklós Keserű, Jan Hodek, Jan Weber, Ferenc Jakab, Pál Herczegh, Anikó Borbás |
| 152 |
[GO] |
2021―Okt―18 |
The Impact of SARS-CoV-2 Infection, and Application of Immunosuppressive Agents in Kidney Transplant Recipients Suffering from COVID-19 |
Horng-Ta Tseng, Xiang-Chi Wu, Chun-Yao Huang, Chun-Ming Shih, Yi-Wen Lin, Feng-Yen Lin |
| 153 |
[GO] |
2021―Okt―18 |
Side Effects of mRNA-Based COVID-19 Vaccines among Young Adults (18-30 Years Old): An Independent Post-Marketing Study |
Abanoub Riad, Andrea Pokorná, Jitka Klugarová, Natália Antalová, Lucia Kantorová, Michal Koščík, Miloslav Klugar |
| 154 |
[GO] |
2021―Okt―18 |
SARS-CoV-2 Fears Green: The Chlorophyll Catabolite Pheophorbide A Is a Potent Antiviral |
Guillermo H. Jimenez-Aleman, Victoria Castro, Addis Londaitsbehere, Marta Gutierrez-Rodríguez, Urtzi Garaigorta, Roberto Solano, Pablo Gastaminza |
| 155 |
[GO] |
2021―Okt―18 |
In Vitro Effect of Taraxacum officinale Leaf Aqueous Extract on the Interaction between ACE2 Cell Surface Receptor and SARS-CoV-2 Spike Protein D614 and Four Mutants |
Hoai Thi Thu Tran, Michael Gigl, Nguyen Phan Khoi Le, Corinna Dawid, Evelyn Lamy |
| 156 |
[GO] |
2021―Okt―09 |
Targeting SARS-CoV-2 Variants with Nucleic Acid Therapeutic Nanoparticle Conjugates |
Hanah F. Huber, Majid Jaberi-Douraki, Sarah DeVader, Cesar Aparicio-Lopez, Juliet Nava-Chavez, Xuan Xu, Nuwan Indika Millagaha Gedara, Natasha N. Gaudreault, Robert K. Delong |
| 157 |
[GO] |
2021―Sep―28 |
Ginkgolic Acid Inhibits Coronavirus Strain 229E Infection of Human Epithelial Lung Cells |
Maimoona Bhutta, Daniel Sausen, Elisa Gallo, Harel Dahari, Gustavo Doncel, Ronen Borenstein |
| 158 |
[GO] |
2021―Sep―24 |
Pharmacology and Adverse Events of Emergency-Use Authorized Medication in Moderate to Severe COVID-19 |
Jen-Yu Hsu, Yan-Chiao Mao, Po-Yu Liu, Kuo-Lung Lai |
| 159 |
[GO] |
2021―Sep―24 |
A Drug Repurposing Approach for Antimalarials Interfering with SARS-CoV-2 Spike Protein Receptor Binding Domain (RBD) and Human Angiotensin-Converting Enzyme 2 (ACE2) |
Paolo Coghi, Li Jun Yang, Jerome P. L. Ng, Richard K. Haynes, Maurizio Memo, Alessandra Gianoncelli, Vincent Kam Wai Wong, Giovanni Ribaudo |
| 160 |
[GO] |
2021―Sep―18 |
Neuropsychiatric Disorders and COVID-19: What We Know So Far |
Fernanda Majolo, Guilherme Liberato da Silva, Lucas Vieira, Cetin Anli, Luís Fernando Saraiva Macedo Timmers, Stefan Laufer, Márcia Inês Goettert |
| 161 |
[GO] |
2021―Sep―06 |
In Silico Prediction of Novel Inhibitors of SARS-CoV-2 Main Protease through Structure-Based Virtual Screening and Molecular Dynamic Simulation |
Sobia Ahsan Halim, Muhammad Waqas, Ajmal Khan, Ahmed Al-Harrasi |
| 162 |
[GO] |
2021―Sep―03 |
Sub-Micromolar Inhibition of SARS-CoV-2 3CLpro by Natural Compounds |
Bruno Rizzuti, Laura Ceballos-Laita, David Ortega-Alarcon, Ana Jimenez-Alesanco, Sonia Vega, Fedora Grande, Filomena Conforti, Olga Abian, Adrian Velazquez-Campoy |
| 163 |
[GO] |
2021―Sep―01 |
Synthesis and Biological Evaluation of Honokiol Derivatives Bearing 3-((5-phenyl-1,3,4-oxadiazol-2-yl)methyl)oxazol-2(3H)-ones as Potential Viral Entry Inhibitors against SARS-CoV-2 |
Yong Guo, Jie-Ru Meng, Jia-Zheng Liu, Ting Xu, Zhi-Yuan Zheng, Zhi-Hong Jiang, Li-Ping Bai |
| 164 |
[GO] |
2021―Aug―31 |
Side Effects of mRNA-Based COVID-19 Vaccine: Nationwide Phase IV Study among Healthcare Workers in Slovakia |
Abanoub Riad, Barbora Hocková, Lucia Kantorová, Rastislav Slávik, Lucia Spurná, Adam Stebel, Michal Havriľak, Miloslav Klugar |
| 165 |
[GO] |
2021―Aug―23 |
Pharmacological Interactions of Nintedanib and Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis in Times of COVID-19 Pandemic |
José M. Serra López-Matencio, Manuel Gómez, Esther F. Vicente-Rabaneda, Miguel A. González-Gay, Julio Ancochea, Santos Castañeda |
| 166 |
[GO] |
2021―Aug―23 |
Correction: Zanella et al. Tenofovir, Another Inexpensive, Well Known and Widely Available Old Drug Repurposed for SARS-COV-2 Infection. Pharmaceuticals 2021, 14, 454 |
Isabella Zanella, Daniela Zizioli, Francesco Castelli, Eugenia Quiros-Roldan |
| 167 |
[GO] |
2021―Aug―18 |
Angiotensin-Converting Enzyme 2 (ACE2) in the Context of Respiratory Diseases and Its Importance in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection |
Enrique Ambrocio-Ortiz, Gloria Pérez-Rubio, Alma D. Del Ángel-Pablo, Ivette Buendía-Roldán, Leslie Chávez-Galán, Rafael de Jesús Hernández-Zenteno, Alejandra Ramírez-Venegas, Jorge Rojas-Serrano, Mayra Mejía, Rogelio Pérez-Padilla, Cristóbal Guadarrama-Pérez, Ramcés Falfán-Valencia |
| 168 |
[GO] |
2021―Aug―18 |
Lung Fibrosis after COVID-19: Treatment Prospects |
Evgeny Bazdyrev, Polina Rusina, Maria Panova, Fedor Novikov, Ivan Grishagin, Vladimir Nebolsin |
| 169 |
[GO] |
2021―Aug―04 |
Prevalence and Significance of Hypermetabolic Lymph Nodes Detected by 2-[18F]FDG PET/CT after COVID-19 Vaccination: A Systematic Review and a Meta-Analysis |
Giorgio Treglia, Marco Cuzzocrea, Luca Giovanella, Luigia Elzi, Barbara Muoio |
| 170 |
[GO] |
2021―Aug―02 |
Coronavirus Disease (COVID)-19 and Diabetic Kidney Disease |
Swayam Prakash Srivastava, Rohit Srivastava, Subhash Chand, Julie E. Goodwin |
| 171 |
[GO] |
2021―Jul―30 |
Reynoutria Rhizomes as a Natural Source of SARS-CoV-2 Mpro Inhibitors-Molecular Docking and In Vitro Study |
Izabela Nawrot-Hadzik, Mikolaj Zmudziński, Adam Matkowski, Robert Preissner, Małgorzata Kęsik-Brodacka, Jakub Hadzik, Marcin Drag, Renata Abel |
| 172 |
[GO] |
2021―Jul―28 |
Janus Kinase Inhibitors and Coronavirus Disease (COVID)-19: Rationale, Clinical Evidence and Safety Issues |
Milo Gatti, Eleonora Turrini, Emanuel Raschi, Piero Sestili, Carmela Fimognari |
| 173 |
[GO] |
2021―Jul―28 |
Antiviral Therapeutic Approaches for SARS-CoV-2 Infection: A Systematic Review |
Victoria Gil Martínez, Ana Avedillo Salas, Sonia Santander Ballestín |
| 174 |
[GO] |
2021―Jul―19 |
Update on Functional Inhibitors of Acid Sphingomyelinase (FIASMAs) in SARS-CoV-2 Infection |
Gwenolé Loas, Pascal Le Corre |
| 175 |
[GO] |
2021―Jul―19 |
Soluble Angiotensin Converting Enzyme 2 (ACE2) Is Upregulated and Soluble Endothelial Nitric Oxide Synthase (eNOS) Is Downregulated in COVID-19-induced Acute Respiratory Distress Syndrome (ARDS) |
Alice G. Vassiliou, Alexandros Zacharis, Chrysi Keskinidou, Edison Jahaj, Maria Pratikaki, Parisis Gallos, Ioanna Dimopoulou, Anastasia Kotanidou, Stylianos E. Orfanos |
| 176 |
[GO] |
2021―Jul―16 |
Current Status of Baricitinib as a Repurposed Therapy for COVID-19 |
Maha Saber-Ayad, Sarah Hammoudeh, Eman Abu-Gharbieh, Rifat Hamoudi, Hamadeh Tarazi, Taleb H. Al-Tel, Qutayba Hamid |
| 177 |
[GO] |
2021―Jul―15 |
Use of Monoclonal Antibody to Treat COVID-19 in Children and Adolescents: Risk of Abuse of Prescription and Exacerbation of Health Inequalities |
Susanna Esposito, Stefano Zona, Andrea Pession, Lorenzo Iughetti, Giovanni Battista Migliori, Nicola Principi |
| 178 |
[GO] |
2021―Jul―12 |
COVID-19: Failure of the DisCoVeRy Clinical Trial, and Now-New Hopes? |
Jean Jacques Vanden Eynde |
| 179 |
[GO] |
2021―Jun―23 |
Identification of SARS-CoV-2 E Channel Blockers from a Repurposed Drug Library |
Prabhat Pratap Singh Tomar, Miriam Krugliak, Isaiah T. Arkin |
| 180 |
[GO] |
2021―Jun―07 |
Scaffold Hopping of α-Rubromycin Enables Direct Access to FDA-Approved Cromoglicic Acid as a SARS-CoV-2 MPro Inhibitor |
Hani A. Alhadrami, Ahmed M. Sayed, Heba Al-Khatabi, Nabil A. Alhakamy, Mostafa E. Rateb |
| 181 |
[GO] |
2021―Mai―31 |
Clinical Management of COVID-19: A Review of Pharmacological Treatment Options |
Ashli M. Heustess, Melissa A. Allard, Dorothea K. Thompson, Pius S. Fasinu |
| 182 |
[GO] |
2021―Mai―27 |
Immunotherapeutic Efficacy of IgY Antibodies Targeting the Full-Length Spike Protein in an Animal Model of Middle East Respiratory Syndrome Coronavirus Infection |
Sherif A. El-Kafrawy, Aymn T. Abbas, Sayed S. Sohrab, Ashraf A. Tabll, Ahmed M. Hassan, Naoko Iwata-Yoshikawa, Noriyo Nagata, Esam I. Azhar |
| 183 |
[GO] |
2021―Mai―26 |
New Approaches and Repurposed Antiviral Drugs for the Treatment of the SARS-CoV-2 Infection |
Bauso Luana Vittoria, Chiara Imbesi, Gasparo Irene, Gabriella Calì, Alessandra Bitto |
| 184 |
[GO] |
2021―Mai―20 |
Hydrotalcite-Niclosamide Nanohybrid as OralFormulation towards SARS-CoV-2 Viral Infections |
Goeun Choi, Huiyan Piao, N. Sanoj Rejinold, Seungjin Yu, Ki yeok Kim, Geun-woo Jin, Jin-Ho Choy |
| 185 |
[GO] |
2021―Mai―11 |
Tenofovir, Another Inexpensive, Well-Known and Widely Available Old Drug Repurposed for SARS-COV-2 Infection |
Isabella Zanella, Daniela Zizioli, Francesco Castelli, Eugenia Quiros-Roldan |
| 186 |
[GO] |
2021―Apr―26 |
COVID-19 Vaccines: A Review of the Safety and Efficacy of Current Clinical Trials |
Zhi-Peng Yan, Ming Yang, Ching-Lung Lai |
| 187 |
[GO] |
2021―Apr―06 |
Ultramicronized Palmitoylethanolamide (um-PEA): A New Possible Adjuvant Treatment in COVID-19 patients |
Annalisa Noce, Maria Albanese, Giulia Marrone, Manuela Di Lauro, Anna Pietroboni Zaitseva, Daniela Palazzetti, Cristina Guerriero, Agostino Paolino, Giuseppa Pizzenti, Francesca Di Daniele, Annalisa Romani, Cartesio D’Agostini, Andrea Magrini, Nicola Biagio Mercuri, Nicola Di Daniele |
| 188 |
[GO] |
2021―Apr―06 |
Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods |
Tiziana Ginex, Urtzi Garaigorta, David Ramírez, Victoria Castro, Vanesa Nozal, Inés Maestro, Javier García-Cárceles, Nuria E. Campillo, Ana Martinez, Pablo Gastaminza, Carmen Gil |
| 189 |
[GO] |
2021―Mrz―31 |
Potent Antiviral Activity against HSV-1 and SARS-CoV-2 by Antimicrobial Peptoids |
Gill Diamond, Natalia Molchanova, Claudine Herlan, John A. Fortkort, Jennifer S. Lin, Erika Figgins, Nathen Bopp, Lisa K. Ryan, Donghoon Chung, Robert Scott Adcock, Michael Sherman, Annelise E. Barron |
| 190 |
[GO] |
2021―Mrz―08 |
Association between Functional Inhibitors of Acid Sphingomyelinase (FIASMAs) and Reduced Risk of Death in COVID-19 Patients: A Retrospective Cohort Study |
Gil Darquennes, Pascal Le Corre, Olivier Le Moine, Gwenolé Loas |
| 191 |
[GO] |
2021―Mrz―05 |
Rapamycin: Drug Repurposing in SARS-CoV-2 Infection |
Jiri Patocka, Kamil Kuca, Patrik Oleksak, Eugenie Nepovimova, Martin Valis, Michal Novotny, Blanka Klimova |
| 192 |
[GO] |
2021―Mrz―05 |
Repurposing of Some Natural Product Isolates as SARS-COV-2 Main Protease Inhibitors via In Vitro Cell Free and Cell-Based Antiviral Assessments and Molecular Modeling Approaches |
Hossam M. Abdallah, Ali M. El-Halawany, Alaa Sirwi, Amr M. El-Araby, Gamal A. Mohamed, Sabrin R. M. Ibrahim, Abdulrahman E. Koshak, Hani Z. Asfour, Zuhier A. Awan, Mahmoud A. Elfaky |
| 193 |
[GO] |
2021―Feb―25 |
Evaluation of the Antiviral Activity of Sitagliptin-Glatiramer Acetate Nano-Conjugates against SARS-CoV-2 Virus |
Nabil A. Alhakamy, Osama A. A. Ahmed, Tarek S. Ibrahim, Hibah M. Aldawsari, Khalid Eljaaly, Usama A. Fahmy, Ahmed L. Alaofi, Filippo Caraci, Giuseppe Caruso |
| 194 |
[GO] |
2021―Jan―25 |
Identification of 37 Heterogeneous Drug Candidates for Treatment of COVID-19 via a Rational Transcriptomics-Based Drug Repurposing Approach |
Andrea Gelemanović, Tinka Vidović, Višnja Stepanić, Katarina Trajković |
| 195 |
[GO] |
2021―Jan―20 |
COVID-19-The Potential Beneficial Therapeutic Effects of Spironolactone during SARS-CoV-2 Infection |
Katarzyna Kotfis, Kacper Lechowicz, Sylwester Drożdżal, Paulina Niedźwiedzka-Rystwej, Tomasz K. Wojdacz, Ewelina Grywalska, Jowita Biernawska, Magda Wiśniewska, Miłosz Parczewski |
| 196 |
[GO] |
2021―Jan―11 |
Drug Repurposing: Dipeptidyl Peptidase IV (DPP4) Inhibitors as Potential Agents to Treat SARS-CoV-2 (2019-nCoV) Infection |
Praveen P. N. Rao, Amy Trinh Pham, Arash Shakeri, Amna El Shatshat, Yusheng Zhao, Rahul C. Karuturi, Ahmed A. Hefny |
| 197 |
[GO] |
2021―Jan―07 |
Immunogenicity of Multiple Doses of pDNA Vaccines against SARS-CoV-2 |
Iman Almansour, Nabela Calamata Macadato, Thamer Alshammari |
| 198 |
[GO] |
2020―Dez―28 |
Calming the (Cytokine) Storm: Dimethyl Fumarate as a Therapeutic Candidate for COVID-19 |
Cara A. Timpani, Emma Rybalka |
| 199 |
[GO] |
2020―Dez―08 |
Inhibition of SARS-CoV-2 Entry into Host Cells Using Small Molecules |
Kenana Al Adem, Aya Shanti, Cesare Stefanini, Sungmun Lee |
| 200 |
[GO] |
2020―Dez―04 |
FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2 |
Ahmed Mostafa, Ahmed Kandeil, Yaseen A. M. M. Elshaier, Omnia Kutkat, Yassmin Moatasim, Adel A. Rashad, Mahmoud Shehata, Mokhtar R. Gomaa, Noura Mahrous, Sara H. Mahmoud, Mohamed GabAllah, Hisham Abbas, Ahmed El Taweel, Ahmed E. Kayed, Mina Nabil Kamel, Mohamed El Sayes, Dina B. Mahmoud, Rabeh El-Shesheny, Ghazi Kayali, Mohamed A. Ali |
| 201 |
[GO] |
2020―Nov―28 |
Emetine Is Not Ipecac: Considerations for Its Use as Treatment for SARS-CoV2 |
Martin D. Bleasel, Gregory M. Peterson |
| 202 |
[GO] |
2020―Nov―27 |
Repurposing of Plasminogen: An Orphan Medicinal Product Suitable for SARS-CoV-2 Inhalable Therapeutics |
Anna Maria Piras, Ylenia Zambito, Maurizio Lugli, Baldassare Ferro, Paolo Roncucci, Filippo Mori, Alfonso Salvatore, Ester Ascione, Marta Bellini, Roberto Crea |
| 203 |
[GO] |
2020―Nov―10 |
Role of 2-[18F]FDG as a Radiopharmaceutical for PET/CT in Patients with COVID-19: A Systematic Review |
Salvatore Annunziata, Roberto C. Delgado Bolton, Christel-Hermann Kamani, John O. Prior, Domenico Albano, Francesco Bertagna, Giorgio Treglia |
| 204 |
[GO] |
2020―Okt―17 |
Effect of Tocilizumab in Hospitalized Patients with Severe COVID-19 Pneumonia: A Case-Control Cohort Study |
Benjamin Rossi, Lee S. Nguyen, Philippe Zimmermann, Faiza Boucenna, Louis Dubret, Louise Baucher, Helene Guillot, Marie-Anne Bouldouyre, Yves Allenbach, Joe-Elie Salem, Paul Barsoum, Arezki Oufella, Helene Gros |
| 205 |
[GO] |
2020―Okt―16 |
Medicinal Plants to Strengthen Immunity during a Pandemic |
Olga Babich, Stanislav Sukhikh, Alexander Prosekov, Lyudmila Asyakina, Svetlana Ivanova |
| 206 |
[GO] |
2020―Sep―09 |
Can Nuclear Imaging of Activated Macrophages with Folic Acid-Based Radiotracers Serve as a Prognostic Means to Identify COVID-19 Patients at Risk? |
Cristina Müller, Roger Schibli, Britta Maurer |
| 207 |
[GO] |
2020―Sep―01 |
Zinc(II)-The Overlooked Éminence Grise of Chloroquine’s Fight against COVID-19? |
Aleksandra Hecel, Małgorzata Ostrowska, Kamila Stokowa-Sołtys, Joanna Wątły, Dorota Dudek, Adriana Miller, Sławomir Potocki, Agnieszka Matera-Witkiewicz, Alicia Dominguez-Martin, Henryk Kozłowski, Magdalena Rowińska-Żyrek |
| 208 |
[GO] |
2020―Aug―10 |
Emerging Therapeutic Modalities against COVID-19 |
Shipra Malik, Anisha Gupta, Xiaobo Zhong, Theodore P. Rasmussen, Jose E. Manautou, Raman Bahal |
| 209 |
[GO] |
2020―Jul―28 |
Squalene Emulsion Manufacturing Process Scale-Up for Enhanced Global Pandemic Response |
Tony Phan, Christian Devine, Erik D. Laursen, Adrian Simpson, Aaron Kahn, Amit P. Khandhar, Steven Mesite, Brad Besse, Ken J. Mabery, Elizabeth I. Flanagan, Christopher B. Fox |
| 210 |
[GO] |
2020―Jul―27 |
Immune Pathogenesis of COVID-19 Intoxication: Storm or Silence? |
Mikhail Kiselevskiy, Irina Shubina, Irina Chikileva, Suria Sitdikova, Igor Samoylenko, Natalia Anisimova, Kirill Kirgizov, Amina Suleimanova, Tatyana Gorbunova, Svetlana Varfolomeeva |
| 211 |
[GO] |
2020―Jul―20 |
Substance Use Disorder in the COVID-19 Pandemic: A Systematic Review of Vulnerabilities and Complications |
Yufeng Wei, Rameen Shah |
| 212 |
[GO] |
2020―Jul―06 |
Cancer Patients Have a Higher Risk Regarding COVID-19 - and Vice Versa? |
Franz Geisslinger, Angelika M. Vollmar, Karin Bartel |
| 213 |
[GO] |
2020―Jun―25 |
Preliminary Virtual Screening Studies to Identify GRP78 Inhibitors Which May Interfere with SARS-CoV-2 Infection |
Andreia Palmeira, Emília Sousa, Aylin Köseler, Ramazan Sabirli, Tarık Gören, İbrahim Türkçüer, Özgür Kurt, Madalena M. Pinto, M. Helena Vasconcelos |
| 214 |
[GO] |
2020―Mai―14 |
The Rationale for Potential Pharmacotherapy of COVID-19 |
Maha Saber-Ayad, Mohamed A. Saleh, Eman Abu-Gharbieh |
| 215 |
[GO] |
2020―Mai―14 |
COVID-19: An Update About the Discovery Clinical Trial |
Jean Jacques Vanden Eynde |
| 216 |
[GO] |
2020―Apr―13 |
COVID-19: A Brief Overview of the Discovery Clinical Trial |
Jean Jacques Vanden Eynde |
| 217 |
[GO] |
2020―Mrz―23 |
Emetine, Ipecac, Ipecac Alkaloids and Analogues as Potential Antiviral Agents for Coronaviruses |
Martin D Bleasel, Gregory M Peterson |
|
